Survival analysis of patients with/without lymph node examination after lung cancer resection.

Authors

Raymond Osarogiagbon

R. U. Osarogiagbon

University of Tennessee Cancer Institute, Memphis, TN

R. U. Osarogiagbon , R. A. Ramirez , C. Wang , L. E. Miller , M. Ul-Haq , A. Farooq , J. W. Allen , D. Spencer , A. Berry , A. B. Weir III, H. Cole , T. O'Brien

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2011 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Lung Cancer - Local-regional and Adjuvant Therapy/Small Cell

Track

Lung Cancer

Sub Track

Local-Regional Therapy

Citation

J Clin Oncol 29: 2011 (suppl; abstr 7054)

Abstract #

7054

Poster Bd #

23B

Abstract Disclosures

Similar Posters

First Author: Tawee Tanvetyanon

Poster

2023 ASCO Annual Meeting

The intersection of neighborhood-level disadvantage and overall lung cancer survival.

The intersection of neighborhood-level disadvantage and overall lung cancer survival.

First Author: Kathleen Kennedy

Poster

2023 ASCO Annual Meeting

<span>Two-year lung cancer survival between 2000 to 2020: Results from 3 French nationwide cohorts.</span>

Two-year lung cancer survival between 2000 to 2020: Results from 3 French nationwide cohorts.

First Author: Didier Debieuvre

Poster

2019 ASCO Quality Care Symposium

Impact of dual-eligible status on survival in Medicare patients with lung cancer.

Impact of dual-eligible status on survival in Medicare patients with lung cancer.

First Author: Meera Vimala Ragavan